Skip to main content
Equibles

UBS Group AG

Position in CELZ — Creative Medical Technology Holdings, Inc.

CIK 1610520 ZURICH, V8
Back to CELZ Full portfolio

Position in CELZ

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,987
+$2,985 QoQ
Shares Held
2,061
+206000.0% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 15 holders
Holding Since
Mar 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CELZ Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,672,124 across 561 Biotechnology names. CELZ ranks #487 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in CELZ

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,987 2,061
2026-03-31 $2 1
2025-12-31 $21 11
2025-09-30 $6 2
2025-06-30 $5 2
2025-03-31 $4 2
2024-12-31 $2 1
2024-09-30 $8,447 2,725
2024-03-31 $15,963 3,064
2023-12-31 $4,803 1,042
2023-09-30 $5,372 1,092
2023-06-30 $92 20
2022-12-31 $11,777 30,904
2022-09-30 $4,744 10,782
2022-03-31 $35,724 9,160